Jill A Hoffman

Summary

Affiliation: University of Southern California
Country: USA

Publications

  1. ncbi Escherichia coli K1 aslA contributes to invasion of brain microvascular endothelial cells in vitro and in vivo
    J A Hoffman
    Division of Infectious Diseases, Childrens Hospital Los Angeles, Los Angeles, California 90027, USA
    Infect Immun 68:5062-7. 2000
  2. ncbi Adenovirus infections in solid organ transplant recipients
    Jill A Hoffman
    Department of Pediatrics, University of Southern California, Childrens Hospital Los Angeles, 90027, USA
    Curr Opin Organ Transplant 14:625-33. 2009
  3. ncbi Adenoviral disease in pediatric solid organ transplant recipients
    Jill A Hoffman
    Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
    Pediatr Transplant 10:17-25. 2006
  4. ncbi Human leukocyte antigen-DR expression on peripheral blood monocytes and the risk of pneumonia in pediatric lung transplant recipients
    J A Hoffman
    Department of Pediatrics, Division of Infectious Diseases, Childrens Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, California 90027, USA
    Transpl Infect Dis 6:147-55. 2004
  5. ncbi Streptococcus pneumoniae infections in the neonate
    Jill A Hoffman
    Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California, USA
    Pediatrics 112:1095-102. 2003
  6. ncbi Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation
    J A Hoffman
    Department of Pediatrics, Childrens Hospital Los Angeles and Keck School of Medicine, University of Southern California, 90027, USA
    Biol Blood Marrow Transplant 7:388-94. 2001
  7. ncbi Escherichia coli K1 purA and sorC are preferentially expressed upon association with human brain microvascular endothelial cells
    J A Hoffman
    Division of Infectious Diseases, Children s Hospital Los Angeles, Los Angeles, CA 90027, U S A
    Microb Pathog 31:69-79. 2001
  8. ncbi Prospective monitoring for invasive aspergillosis using galactomannan and polymerase chain reaction in high risk pediatric patients
    Saro H Armenian
    Department of Population Sciences, City of Hope National Medical Center, Duarte, CA, USA
    J Pediatr Hematol Oncol 31:920-6. 2009
  9. ncbi Multicenter surveillance of invasive meningococcal infections in children
    Sheldon L Kaplan
    Pediatric Infectious Diseases Section, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA
    Pediatrics 118:e979-84. 2006
  10. ncbi Invasive diagnostic procedures for pulmonary infiltrates in pediatric hematopoietic stem cell transplant recipients
    Saro H Armenian
    Division of Hematology Oncology, Childrens Hospital Los Angeles, Los Angeles, CA, USA
    Pediatr Transplant 11:736-42. 2007

Detail Information

Publications12

  1. ncbi Escherichia coli K1 aslA contributes to invasion of brain microvascular endothelial cells in vitro and in vivo
    J A Hoffman
    Division of Infectious Diseases, Childrens Hospital Los Angeles, Los Angeles, California 90027, USA
    Infect Immun 68:5062-7. 2000
    ..Complementation of the decreased-invasion phenotypes of these mutants was achieved when aslA was supplied in trans. This is the first demonstration that this locus contributes to invasion of the blood-brain barrier by E. coli K1...
  2. ncbi Adenovirus infections in solid organ transplant recipients
    Jill A Hoffman
    Department of Pediatrics, University of Southern California, Childrens Hospital Los Angeles, 90027, USA
    Curr Opin Organ Transplant 14:625-33. 2009
    ..This review will discuss the current understanding of the epidemiology, diagnosis and therapy of adenovirus infection in transplant recipients...
  3. ncbi Adenoviral disease in pediatric solid organ transplant recipients
    Jill A Hoffman
    Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
    Pediatr Transplant 10:17-25. 2006
    ..Issues related to diagnosis, notably the use of newer non-culture based viral detection methods and therapy, including anti-adenoviral agents and adoptive immunotherapy are discussed...
  4. ncbi Human leukocyte antigen-DR expression on peripheral blood monocytes and the risk of pneumonia in pediatric lung transplant recipients
    J A Hoffman
    Department of Pediatrics, Division of Infectious Diseases, Childrens Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, California 90027, USA
    Transpl Infect Dis 6:147-55. 2004
    ..In addition, interleukin (IL)-10 has been shown to be a negative regulator of HLA-DR expression. This study investigates whether HLA-DR expression and serum IL-10 levels correlate with the development of pneumonia after pediatric LT...
  5. ncbi Streptococcus pneumoniae infections in the neonate
    Jill A Hoffman
    Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California, USA
    Pediatrics 112:1095-102. 2003
    ..The aim of this study was to review the current epidemiology and clinical course of SPIN...
  6. ncbi Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation
    J A Hoffman
    Department of Pediatrics, Childrens Hospital Los Angeles and Keck School of Medicine, University of Southern California, 90027, USA
    Biol Blood Marrow Transplant 7:388-94. 2001
    ..Prospective controlled trials to further define the role of CDV in the treatment of ADV infections in HSCT patients are warranted...
  7. ncbi Escherichia coli K1 purA and sorC are preferentially expressed upon association with human brain microvascular endothelial cells
    J A Hoffman
    Division of Infectious Diseases, Children s Hospital Los Angeles, Los Angeles, CA 90027, U S A
    Microb Pathog 31:69-79. 2001
    ..We have identified novel phenotypes associated with E. coli K1 purA and sorC, which provide evidence that these genes contribute to the invasion of HBMEC...
  8. ncbi Prospective monitoring for invasive aspergillosis using galactomannan and polymerase chain reaction in high risk pediatric patients
    Saro H Armenian
    Department of Population Sciences, City of Hope National Medical Center, Duarte, CA, USA
    J Pediatr Hematol Oncol 31:920-6. 2009
    ..We evaluated the utility of prospective monitoring for invasive aspergillosis (IA) using biomarkers such as serum galactomannan (GM) and/or blood polymerase chain reaction (PCR) in high-risk pediatric patients...
  9. ncbi Multicenter surveillance of invasive meningococcal infections in children
    Sheldon L Kaplan
    Pediatric Infectious Diseases Section, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA
    Pediatrics 118:e979-84. 2006
    ..The objective of this study was to collect demographic, clinical, laboratory, and outcome information for infants and children who had Neisseria meningitidis infections of various serogroups and were cared for in 10 pediatric hospitals...
  10. ncbi Invasive diagnostic procedures for pulmonary infiltrates in pediatric hematopoietic stem cell transplant recipients
    Saro H Armenian
    Division of Hematology Oncology, Childrens Hospital Los Angeles, Los Angeles, CA, USA
    Pediatr Transplant 11:736-42. 2007
    ..In conclusion, all three invasive diagnostic procedures were safe. Having a focal infiltrate was independently and significantly associated with having a positive diagnostic yield...
  11. ncbi The role of bronchoalveolar lavage galactomannan in the diagnosis of pediatric invasive aspergillosis
    Rishi Desai
    Dvision of Infectious Disease, Childrens Hospital Los Angeles, Los Angeles, CA, USA
    Pediatr Infect Dis J 28:283-6. 2009
    ..The use of bronchoalveolar lavage galactomannan (BAL GM) is being validated in adult populations, but has not been systematically evaluated in pediatric patients...
  12. ncbi Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine
    Sheldon L Kaplan
    Pediatric Infectious Diseases Sections of the Baylor College of Medicine, Houston, Texas, USA
    Pediatrics 113:443-9. 2004
    ....